Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furazolidone-containing regimens for Helicobacter pylori eradication
IRCT2013120715701N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of furazolidone in Helicobacter pylori infection and Peptic ulcer disease (PUD), sponsored by Mazandaran University of Medical Sciences. Started Jun 2012; status: completed.
02
Drugs
furazolidone
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on IRCT2013120715701N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013120715701N1.